Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

TAG:

CMS

Behind the Cat-and-Mouse Game of Lab Reimbursement

Financial relationships between clinical laboratories and commercial payers have evolved into a high-stakes, technological tug-of-war. For nearly a decade, the clinical laboratory industry has wrestled with the provisions of the Protecting Acce…

Read More



May 26, 2026, Intelligence: Late-Breaking Lab News

UnitedHealthcare is expanding rural healthcare initiatives that could provide operational relief for clinical laboratories in underserved communities. The effort focuses on improving cash flow, reducing administrative burdens, and strengthening financial stability for rural hospitals an…

Read More



Expect RESULTS Act Vote by End of the Year

CEO SUMMARY: Evidence at the 2026 Executive War College suggests a coming push in clinical lab advocacy, focusing on the RESULTS Act to establish a permanent, database-driven reimbursement model. Simultaneously, federal regulators have floated the idea of heightened scruti…

Read More



In Earnings Calls, Execs at Quest and Labcorp Push for RESULTS Act

Chief executives at Labcorp and Quest Diagnostics made it clear during recent investor calls that they want Congress to pass the RESULTS Act. The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act is seen b…

Read More



March 23, 2026, Intelligence: Late-Breaking Lab News

LinkedIn’s “Skills on the Rise” report shows that shifting workforce demands are reshaping clinical laboratory roles. Released on Feb. 24, the report looked at the 10 fastest-growing skills in the healthcare industry. The data signals that technical expertise alone is no longer su…

Read More



PAMA Cuts Averted Until ‘27; Labs Plan Next Move

CEO SUMMARY: Clinical laboratories have again avoided a potential financial disaster, at least for now, after Congress shifted PAMA cuts to test reimbursement rates until January 2027. However, the victory is temporary absent permanent PAMA reform. To that end, laboratory …

Read More



Cuts to Rural Labs Boost RESULTS Act Support

CEO SUMMARY: Two related legislative concerns should have the sharp attention of clinical laboratory leaders, particularly those in rural areas. On one end, PAMA cuts are scheduled to hit on Jan. 31 short of another reprieve from Congress. Meanwhile, lawmakers at a recent …

Read More



CAP Regains VA Lab Accreditation Contract

CEO SUMMARY: In a blow to The Joint Commission, the US Department of Veterans Affairs has awarded a new clinical laboratory accreditation contract to the College of American Pathologists (CAP). The decision highlights the competition between the two accrediting organizatio…

Read More



Accreditors Explain Changes to CLIA Supervisor Qualifications

In December 2023, the Centers for Medicare and Medicaid Services (CMS) announced major updates to the Clinical Laboratory Improvement Amendments (CLIA) personnel regulations, which went into effect on December 28, 2024. During a panel discussio…

Read More



Could AI Oversight in Labs Fall Under a CLIA Model?

CEO SUMMARY: Clinical AI is advancing faster than regulation, creating risk for medical labs. An expert discusses using CLIA to oversee development and ensure safety, performance, and accountability while complementing FDA oversight. Lab leaders face regulatory uncertainty…

Read More



How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

;